Increasing prevalence
of cardiovascular disorders and growing global geriatric population is expected
to serve as high impact rendering driver for the heart blocks treatment market
over the forecast period. Furthermore, minimally invasive cardiovascular
treatment and evolution of pacemakers coupled with changing lifestyle, genetic
disorder and developing healthcare infrastructure are expected to boost market
growth. Minimally invasive cardiovascular surgeries are now preferred over open
surgeries, owing to the advantages associated with it such as lower risk of
bleeding and infection, shorter duration of stay at hospital, shorter recovery
duration, and minimal surgical scarring.
Heart blocks treatment
market is segmented on the basis of type, treatment and end-use. On the basis
of type, the market is classified into, first-degree heart block, second-degree
heart block and third-degree heart block. As of 2013, first-degree heart block
held the largest market share. Key factors attributing to its large share
includes rising prevalence of first-degree hearth block due to improper
lifestyle and lack of physical activity. Transcutaneous pacing (TCP),
pacemaker, medication and follow-up electrophysiology study are amongst
treatment options included in the scope of study. Pacemakers held the majority
of market share in 2013. Key factors attributing for the higher uses of
pacemakers include its small size and non-reactive metallic encasing, easily to
implant, automatic resynchronization of the heart and enhances electric signal
across the heart.
Geographically, the
heart blocks treatment market is studied with respect to North America, Europe,
Asia Pacific and RoW. North America emerged as the most lucrative regional
market owing to the presence of strong R&D, availability of advanced
technology, favorable reimbursement policies and increased patient awareness.
Asia Pacific is expected to grow at a lucrative CAGR over the forecast period
owing to economic development in countries such as India and China coupled with
increasing healthcare expenditure, growing patient awareness pertaining to the
heart related disorders.
Key players operating
in heart blocks treatment include, Boston Scientific Corporation, Medtronic
Inc., BIOTRONIK SE & Co. KG., Sorin Group and St. Jude Medical, Inc.
Request TOC of “HeartBlocks Treatment Market Analysis Report "
No comments:
Post a Comment